Blood Pressure Obesity Quality of Life 
Cardiometabolic Health Congress
JANUARY 3, 2024
In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.
GEMMS
NOVEMBER 22, 2023
By prioritizing cardiovascular health, individuals can improve their quality of life and longevity. Cardiovascular health is of utmost importance as it directly affects the well-being of our heart and blood vessels. Moreover, a healthy heart contributes to improved overall fitness, endurance, and quality of life.
MIBHS
NOVEMBER 30, 2023
While it’s well-known that mental health issues like anxiety and depression can profoundly impact one’s quality of life, what’s often overlooked is their potential to affect physical health, particularly the heart. People with anxiety often experience elevated heart rates and increased blood pressure.
GEMMS
MAY 22, 2024
Traditional tools like stethoscopes, blood pressure gauges, and electrocardiograms (ECG) are fundamental for standard diagnostic practices. Much of heart disease is linked to conditions like diabetes, obesity, or chronic kidney disease, and specific mutations in nucleic acids help identify them.
Dr. Paddy Barrett
AUGUST 9, 2024
The 14 Factors Include: Hearing Loss High LDL cholesterol Less Education Traumatic Brain Injury Depression Social Isolation Hypertension Obesity Smoking Excess Alcohol Diabetes Physical Inactivity Air Pollution Visual Loss Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission When You Intervene Matters.
Dr. Paddy Barrett
APRIL 12, 2024
Less major diseases earlier in life. Healthspan A common refrain I hear is, “ I have no interest in living longer if I do not have a good quality of life ” However, one of the single biggest factors impacting your quality of life will be whether or not you have a major chronic disease. Less diabetes.
CardiacWire
AUGUST 14, 2024
Rivus Pharmaceuticals’ HU6 is showing promise as a future obesity-related HFpEF treatment, after topline results from its Phase 2a HuMAIN trial revealed valuable weight, symptom, and cardiometabolic improvements – without the risk of muscle loss. blood pressure, pulse, glucose control, inflammation, lipid levels, and liver enzymes).
Expert insights. Personalized for you.
97 
Let's personalize your content